Zobrazeno 1 - 10
of 105
pro vyhledávání: '"T W, JOHNSON"'
Autor:
J. Guan, E. R. Tucker, H. Wan, D. Chand, L. S. Danielson, K. Ruuth, A. El Wakil, B. Witek, Y. Jamin, G. Umapathy, S. P. Robinson, T. W. Johnson, T. Smeal, T. Martinsson, L. Chesler, R. H. Palmer, B. Hallberg
Publikováno v:
Disease Models & Mechanisms, Vol 9, Iss 9, Pp 941-952 (2016)
The first-in-class inhibitor of ALK, c-MET and ROS1, crizotinib (Xalkori), has shown remarkable clinical efficacy in treatment of ALK-positive non-small cell lung cancer. However, in neuroblastoma, activating mutations in the ALK kinase domain are ty
Externí odkaz:
https://doaj.org/article/0874c752cd854424a6b9a3ca42147e8d
Publikováno v:
European Heart Journal. 42
Background Despite improvements in therapy for heart failure, the prognosis remains poor. Energetic imbalances related to mitochondrial dysfunction, impaired oxidative phosphorylation and oxidative damage have been implicated in the pathogenesis or w
Publikováno v:
European Heart Journal. 42
Background The prognosis of heart failure remains poor. Energetic imbalances related to mitochondrial dysfunction, impaired oxidative phosphorylation and oxidative damage have been implicated in the pathogenesis or worsening of heart failure (1,2). I
Autor:
M G L Williams, K Liang, E De Garate, L Spagnoli, E Fiori, C B Lawton, A Dastidar, T W Johnson, G Biglino, C Bucciarelli-Ducci
Publikováno v:
European Heart Journal. 42
Background Up to 10% of patients who present with an acute coronary syndrome have a myocardial infarction with non-obstructive coronary arteries (MINOCA). Troponin T predicts infarct size and outcomes in patients with ST-elevation myocardial infarcti
Autor:
Ganesh Umapathy, Yann Jamin, B. Witek, Simon P. Robinson, Jikui Guan, H. Wan, Damini Chand, Laura Danielson, Kristina Ruuth, T. W. Johnson, T. Smeal, Tommy Martinsson, Ruth H. Palmer, Elizabeth R. Tucker, Louis Chesler, A. El Wakil, B. Hallberg
Publikováno v:
Europe PubMed Central
Disease Models & Mechanisms, Vol 9, Iss 9, Pp 941-952 (2016)
Disease Models & Mechanisms
Disease Models & Mechanisms, Vol 9, Iss 9, Pp 941-952 (2016)
Disease Models & Mechanisms
The first-in-class inhibitor of ALK, c-MET and ROS1, crizotinib (Xalkori), has shown remarkable clinical efficacy in treatment of ALK-positive non-small cell lung cancer. However, in neuroblastoma, activating mutations in the ALK kinase domain are ty
Publikováno v:
Antibioticschemotherapy (Northfield, Ill.). 3(3)
Autor:
C W, JOHNSON, T W, JOHNSON
Publikováno v:
Antibioticschemotherapy (Northfield, Ill.). 1(9)
Publikováno v:
The Journal of Physical Chemistry B. 104:836-847
Low temperature (4.2 K) absorption and hole-burned spectra are presented for the trimeric (wild-type, WT) photosystem I complex of the cyanobacterium Synechocystis sp. PCC 6803, its monomeric form, and mutants deficient in the PsaF, K, L, and M prote
Autor:
R. A. Lindgren, T. W. Johnson, B. L. Clausen, R. J. Peterson, H. Ward, A. D. Bacher, A. L. Williams, K. Cromer
Publikováno v:
Physical Review C. 55:625-639
Inelastic ${\ensuremath{\pi}}^{\ifmmode\pm\else\textpm\fi{}}$ differential cross-section measurements at a pion incident energy of 162 MeV were made for 12 ${(f}_{7/2}^{}{d}_{5/2}^{}\ensuremath{-}1)$ 6${}^{\ensuremath{-}}$ states in ${}^{32}$S, inclu
Autor:
David E. Padgett, T. W. Johnson
Publikováno v:
Mycologia. 96:205-207
Inadequate attention to zoosporangial discharge has led to confusion in watermold taxonomic literature. This problem is discussed in light of a specimen of Protoachlya hypogyna that manifests disch...